Bullisch
$10.79
Szenariopreis
$7.370
-0.137 (-1.86%)Zum Schluss
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.
Roth Capital
$12
2026-03-13
Roth Capital
2026-03-13
Kursziel
$12
B. Riley
$9
2025-11-07
B. Riley
2025-11-07
Kursziel
$9
Lake Street
$11
2025-11-07
Lake Street
2025-11-07
Kursziel
$11
Roth Capital
$14
2025-11-07
Roth Capital
2025-11-07
Kursziel
$14
Lake Street
$16
2025-05-09
Lake Street
2025-05-09
Kursziel
$16
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

The Joint Corp. to Report Q3 Financial Results on November 5, 2026

Texas Territory Reacquisition Enhances The Joint's Franchise Growth Strategy

The Joint Reacquires Texas Development Rights to Accelerate Franchise Growth

The Joint Corp. Recognized as Top Brand for Multi-Unit Owners

The Joint Chiropractic Recognized as Top Brand for Multi-Unit Owners
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).
Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.
3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.